Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Appearance of IgE antibodies to ingested and inhaled allergens during the first 12 years of life in atopic and non‐atopic children

View through CrossRef
The appearance and course of serum immunoglobulin E‐antibodies (IgE‐ab) to egg‐white (EW). cow's milk (CM) and inhalants (pollen, danders and mite) were followed from birth to 12 years of age in 84 children unselected for family history of atopy. During the follow‐up 36 children developed atopic symptoms and 48 children did not. IgE‐ab to EW and CM reached a peak prevalence at 8 months of age — with high concentrations almost exclusively in atopies and disappeared successively during childhood. IgE‐ab to inhalants appeared from 2 years of age and then in increasing frequency during childhood. Similar to the pattern of IgE‐ab to EW and CM, transient low levels of IgE‐ab to inhalants were commonly encountered in non‐atopic children while high concentrations without tendency to decline were almost exclusively seen in atopies. High responders to EW‐antigen during infancy were usually also high responders to inhalants during childhood. Clinical allergy to EW and CM and subsequent tolerance appeared early in childhood, whereas allergy to inhalants appeared later and did not disappear. The temporary low‐grade IgE antibody response in non‐atopic individuals to eaten and inhaled allergens is similar to the results of animal studies demonstrating a transient IgE production followed by tolerance.
Title: Appearance of IgE antibodies to ingested and inhaled allergens during the first 12 years of life in atopic and non‐atopic children
Description:
The appearance and course of serum immunoglobulin E‐antibodies (IgE‐ab) to egg‐white (EW).
cow's milk (CM) and inhalants (pollen, danders and mite) were followed from birth to 12 years of age in 84 children unselected for family history of atopy.
During the follow‐up 36 children developed atopic symptoms and 48 children did not.
IgE‐ab to EW and CM reached a peak prevalence at 8 months of age — with high concentrations almost exclusively in atopies and disappeared successively during childhood.
IgE‐ab to inhalants appeared from 2 years of age and then in increasing frequency during childhood.
Similar to the pattern of IgE‐ab to EW and CM, transient low levels of IgE‐ab to inhalants were commonly encountered in non‐atopic children while high concentrations without tendency to decline were almost exclusively seen in atopies.
High responders to EW‐antigen during infancy were usually also high responders to inhalants during childhood.
Clinical allergy to EW and CM and subsequent tolerance appeared early in childhood, whereas allergy to inhalants appeared later and did not disappear.
The temporary low‐grade IgE antibody response in non‐atopic individuals to eaten and inhaled allergens is similar to the results of animal studies demonstrating a transient IgE production followed by tolerance.

Related Results

IgE glycans promote IgG anti-IgE autoantibodies that facilitate IgE serum clearance via CD23
IgE glycans promote IgG anti-IgE autoantibodies that facilitate IgE serum clearance via CD23
Background : IgE antibodies are involved in type-1 hypersensitivity. Cross-linking IgE bound to the high-affinity IgE receptor, FceRI on effector cells with an al...
Effects of syngeneic anti-IgE antibodies on the development of IgE memory and on the secondary IgE response.
Effects of syngeneic anti-IgE antibodies on the development of IgE memory and on the secondary IgE response.
Abstract The prolonged inhibition of IgE synthesis in mice caused by perinatal inoculation of IgE is attributable, at least in part, to the formation of anti-IgE ...
Genesis of host IgE competence: perinatal IgE tolerance induced by IgE processed and presented by IgE Fc receptor (CD23)‐bearing B cells
Genesis of host IgE competence: perinatal IgE tolerance induced by IgE processed and presented by IgE Fc receptor (CD23)‐bearing B cells
AbstractA murine model for studying life‐long IgE tolerance was previously developed in this laboratory by perinatal IgE injection into neonates. Herein, we demonstrated that norma...
In vitro binding of an IgE protein to human platelets.
In vitro binding of an IgE protein to human platelets.
Abstract Bronchoconstriction in extrinsic asthma is initiated by mediators released from IgE-sensitized leukocytes after contact with polyvalent antigen. Because pla...
Clinical symptoms and IgE responses to common food proteins in atopic and healthy children
Clinical symptoms and IgE responses to common food proteins in atopic and healthy children
SummaryThe appearance of symptoms suggestive of allergy through the first 4 years of life was studied prospectively in eighty‐six healthy newborn babies. Blood samples were obtaine...
Anti-IgE monoclonal antibodies that bind to IgE bound by CD23 but not to IgE bound by IgE Fc receptors on basophils (86.10)
Anti-IgE monoclonal antibodies that bind to IgE bound by CD23 but not to IgE bound by IgE Fc receptors on basophils (86.10)
Abstract IgE is a central mediator responsible for immediate-type hypersensitivity reactions. The anti-IgE monoclonal antibody (mAb), omalizumab, has been shown i...
Inhibition of IgE synthesis by anti-IgE: role in long-term inhibition of IgE synthesis by neonatally administered soluble IgE.
Inhibition of IgE synthesis by anti-IgE: role in long-term inhibition of IgE synthesis by neonatally administered soluble IgE.
Inoculation of syngeneic IgE into 2- to 12-day-old mice results in prolonged synthesis of anti-IgE antibodies without further challenge. These anti-IgE antibodies may be largely re...
IgE response to fur animal allergens and domestic animal allergens in fur farmers and fur garment workers
IgE response to fur animal allergens and domestic animal allergens in fur farmers and fur garment workers
SummaryObjective The aim of this study was to compare the IgE response to the most commonly farmed fur animals with that to domestic animals.Methods IgE‐immunoblotting and RAST‐inh...

Back to Top